Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy

Background: The long-term benefits of conversion from calcineurin inhibitors (CNIs) to belatacept in kidney transplant recipients (KTr) are poorly documented. Methods: A single-center retrospective work to study first-time CNI to belatacept conversion as a rescue therapy [eGFR <30 ml/min/1.73 m(2...

Descripción completa

Detalles Bibliográficos
Autores principales: Morel, Antoine, Hoisnard, Léa, Dudreuilh, Caroline, Moktefi, Anissa, Kheav, David, Pimentel, Ana, Sakhi, Hamza, Mokrani, David, Attias, Philippe, El Sakhawi, Karim, Champy, Cécile Maud, Remy, Philippe, Sbidian, Emilie, Grimbert, Philippe, Matignon, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043102/
https://www.ncbi.nlm.nih.gov/pubmed/35497889
http://dx.doi.org/10.3389/ti.2022.10228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043102/
https://www.ncbi.nlm.nih.gov/pubmed/35497889
http://dx.doi.org/10.3389/ti.2022.10228

Ejemplares similares